ライフサイエンスコーパス: NCT

1 NCT and PS1 play important roles in binding amyloid beta

2 NCT and saline groups were treated 10 times for 1 day an

3 NCT at doses that normalize tNEPI may be useful in the t

4 NCT demonstrated antiviral activity against adenovirus i

5 NCT for LTBI reduces its effectiveness.

6 NCT outputs can be monitored throughout developmental st

7 NCT reveals an elongation rate of ~10 amino acids per se

8 NCT-independent gamma-secretase activity can be detected

9 Rabbit study 1: 2.5%, 2.0%, 1.0% NCT, and cidofovir demonstrated significantly fewer posi

10 2, Ad5-infected eyes were treated with 1.0% NCT/0.1% ammonium chloride (NH4Cl), 0.1% NCT/1.0% NH4Cl,

11 Rabbit study 2: 1.0% NCT/0.1% NH4Cl, 0.1% NCT/1.0% NH4Cl, 0.1% NCT/0.1% NH4Cl

12 eyes were treated with 2.5%, 2.0%, and 1.0% NCT; 0.5% cidofovir; or saline.

13 que identifiers: NCT 00289822, NCT 00284713, NCT 00326989, NCT 00962364.

14 Unique identifiers: NCT 00289822, NCT 00284713, NCT 00326989, NCT 00962364.

15 s: NCT 00289822, NCT 00284713, NCT 00326989, NCT 00962364.

16 hyphase (0.7 [95% CI, 0.1 to 0.9]; P = .01), NCT amplitude (0.7 [95% CI, 0.1 to 0.9]; P = .01), and N

17 nts as defined by the presence of at least 1 NCT identifier corresponding to an interventional cancer

18 chloride (NH4Cl), 0.1% NCT/1.0% NH4Cl, 0.1% NCT/0.1% NH4Cl, and 0.5% cidofovir or saline.

19 0% NCT/0.1% NH4Cl, 0.1% NCT/1.0% NH4Cl, 0.1% NCT/0.1% NH4Cl, and cidofovir demonstrated significantly

20 .0% NCT/0.1% ammonium chloride (NH4Cl), 0.1% NCT/1.0% NH4Cl, 0.1% NCT/0.1% NH4Cl, and 0.5% cidofovir

21 Rabbit study 2: 1.0% NCT/0.1% NH4Cl, 0.1% NCT/1.0% NH4Cl, 0.1% NCT/0.1% NH4Cl, and cidofovir demon

22 s to conclude that, although the PS1, APH-1, NCT, and PEN-2 are essential for gamma-secretase activit

23 ll lines that stably overexpress PS1, APH-1, NCT, and PEN-2, PS1 fragment levels are elevated by up t

24 ma-secretase activity, we coexpressed APH-1, NCT, and PS1 together with a series of PEN-2 mutants, wh

25 ibuted to an adverse event [NCT-AE] and 1089 NCT attributed to reasons other than an adverse event [N

26 linicalTrial.gov Registration Dec 3, 2008: # NCT 00803907.

27 (3HP-DOT = 6.4% vs 9H-SAT = 5.9%; P = .23); NCT-O was higher among participants enrolled in 9H-SAT (

28 (22.6%) did not complete LTBI treatment (317 NCT attributed to an adverse event [NCT-AE] and 1089 NCT

29 T ranged from 33% (Ocuton S) to 66% and 59% (NCT and HAT, respectively).

30 acokinetic evaluation of selected analog 64 (NCT-501) is also highlighted.

31 We show that expression of a NCT-specific scFv clone, G9, in HEK293 cells decreased t

32 ular Ran GTPase, a critical factor of active NCT.

33 ence of axillary lymph node metastases after NCT.

34 is highly correlated with nodal status after NCT, and the risk for missing nodal metastases without a

35 An NCT identifier present in Medicare claims.

36 ed with cancer between 2006 and 2015 with an NCT identifier in claims corresponding to an interventio

37 (1.0%) patients had a billing claim with an NCT identifier indicating enrollment in an interventiona

38 ial, including 3797 patients (75.0%) with an NCT identifier on at least 1 billing claim that matched

39 ude (0.7 [95% CI, 0.1 to 0.9]; P = .01), and NCT midline estimating statistic of rhythm (0.9 [95% CI,

40 These findings suggest that APH-1 and NCT are necessary for stabilization of full-length PS1 a

41 APH-1 and NCT stabilize the PS1 holoprotein, whereas PEN-2 is crit

42 e that in cells coexpressing PS1, APH-1, and NCT, full-length PS1 accumulates to high levels and is f

43 in regulation of cellular RanGTP levels and NCT, RCC1 expression enables the proliferation of cells

44 In PS1(-/-)/PS2(-/-) and NCT(-/-) fibroblasts, gamma-secretase components that st

45 External validation on TCGA-STAD and NCT-CRC-HE-100 K further confirmed the model's robustnes

46 available datasets-GasHisSDB, TCGA-STAD, and NCT-CRC-HE-100 K-were utilized to train and evaluate the

47 rovide a comprehensive pipeline for applying NCT to structural connectomes by following two procedure

48 hway that ensures NPC integrity, appropriate NCT, and nuclear TDP-43 expression and function in adult

49 xis important for NPC integrity, appropriate NCT, and TDP-43 nuclear function in neurons that, when d

50 ylated and disulfide-bonded proteins such as NCT, we produced chimeras between human (hNCT) and Caeno

51 ves itself during its maturation and because NCT-E333A also shows defects in gamma-secretase complex

52 ies reveal that a direct interaction between NCT ectodomain and APP(C99) influences the stability of

53 and indicating that the interactions between NCT with PS1 may be indirect or stabilized by the presen

54 duration who were evaluated on admission by NCT, PCT, and CTA, and underwent a follow-up CT/CTA or m

55 tients who receive neoadjuvant chemotherapy (NCT) have a tumor response, a small proportion experienc

56 f the breast after neoadjuvant chemotherapy (NCT) indicates pCR in the breast (hereinafter referred t

57 atients undergoing neoadjuvant chemotherapy (NCT).

58 We provide recommendations for comparing NCT outputs against null network models, and we further

59 symbol, block design, and number connection [NCT-A and B]) and the inhibitory control test (ICT).

60 ing three different tonometers: non-contact (NCT), the ICare and Goldmann applanation (GAT).

61 sh that gamma-secretase complexes containing NCT-E333A are indeed deficient in intrinsic activity.

62 pramolecular bonding interactions to control NCT assembly, as well as an understanding of how the org

63 To date, NCT has been validated to study different aspects of the

64 assembly, we generated nicastrin-deficient (NCT-/-) mice and derived fibroblasts from NCT-/- embryos

65 HG footprints for four cities (Berlin, Delhi NCT, Mexico City, and New York metropolitan area) applyi

66 NPC disruption, alterations in Ran-dependent NCT, and TDP-43 mislocalization, while genetic reduction

67 e, we present a suite of rationally designed NCT systems, where multiple types of supramolecular inte

68 fd1-Npl4 complex to degrade NPCs and disrupt NCT.

69 ; however, the mechanisms by which disrupted NCT causes neurodegeneration remain unclear.

70 set of nucleoporins from NPCs and disrupting NCT.

71 5 mg/kg twice daily, n=7) (L-NCT), high-dose NCT (2 mg/kg twice daily, n=7) (H-NCT), L-NCT plus enala

72 Dogs were randomized to low-dose NCT (0.5 mg/kg twice daily, n=7) (L-NCT), high-dose NCT

73 Hourly awakening during NCT IOP measurements did not significantly change the me

74 ase, and 59 (3%) had PD at some point during NCT.

75 ntify predictors of tumor progression during NCT with the ultimate aim of identifying patients who mi

76 lls expressing PS1, APH-1, PEN-2, and either NCT-WT or NCT-ER.

77 ween human (hNCT) and Caenorhabditis elegans NCT (ceNCT).

78 No mutations in genes encoding NCT, or PEN-2 have been identified to date that cause AD

79 that membranes from cells expressing NCT-ER, NCT-TGN, or NCT-WT contain identical levels of PS1 deriv

80 Two neuroradiologists evaluated NCT for hypodensity, PCT for infarct core and salvageabl

81 ent (317 NCT attributed to an adverse event [NCT-AE] and 1089 NCT attributed to reasons other than an

82 uted to reasons other than an adverse event [NCT-O]).

83 To validate this proposal, we expressed NCT that lacks the lid entirely, or a variety of NCT var

84 active gamma-secretase resides, we expressed NCT variants harboring either an endoplasmic reticulum (

85 In cells expressing NCT-ER and the other components, PS1 fragments hyperaccu

86 we show that membranes from cells expressing NCT-ER, NCT-TGN, or NCT-WT contain identical levels of P

87 D or NICD, respectively, in cells expressing NCT-ER.

88 he start of treatment (MR1), after the first NCT cycle (MR2), and upon completion of NCT (MR3).

89 A can function as a boron delivery agent for NCT.

90 ide exchange factor for Ran, is critical for NCT activity.

91 f RANBP17, a RAN-binding protein crucial for NCT regulation, exhibited a significant reduction in DYT

92 An interesting development for NCT in the neuroscience field is its application to stud

93 suggested a substrate binding mechanism for NCT, a bilobar structure that involved rotation of the t

94 t (NCT-/-) mice and derived fibroblasts from NCT-/- embryos.

95 high-dose NCT (2 mg/kg twice daily, n=7) (H-NCT), L-NCT plus enalapril (10 mg twice daily, n=8) (L-N

96 ic volume and end-systolic volume, whereas H-NCT did not

97 and 39+/-17 pg/mL respectively), whereas HD-NCT reduced tNEPI to below normal levels (3+/-10 pg/mL).

98 Unique identifier: NCT 00351260.

99 Unique identifier: NCT 02321618.

100 Unique identifiers: NCT 00289822, NCT 00284713, NCT 00326989, NCT 00962364.

101 ntricate molecular underpinnings of impaired NCT in DYT1 neurons and provide novel insights into the

102 ating factor, effectively restoring impaired NCT activity and rescuing neurodevelopmental deficits ob

103 hereas it is reduced by approximately 50% in NCT+/- cells; the failure to generate Abeta peptides in

104 secretion of Abeta peptides is abolished in NCT-/- fibroblasts, whereas it is reduced by approximate

105 Moreover, APP trafficking analysis in NCT-/- fibroblasts revealed a significant delay in the r

106 urodegenerative diseases, whether defects in NCT occur in TBI remains unknown.

107 bservation that a critical residue (E332) in NCT, which had been thought to be essential for gamma-se

108 s; the failure to generate Abeta peptides in NCT-/- cells is accompanied by destabilization of the pr

109 Expression of ALS-FUS led to a reduction in NCT and nucleoporin (Nup) density within the nuclear mem

110 activity can be detected in two independent NCT-deficient mouse embryonic fibroblast lines and block

111 L-NCT alone and L-NCT+ENA reduced tNEPI toward normal (28+

112 L-NCT and L-NCT+ENA prevented progressive LV remodeling, a

113 low-dose NCT (0.5 mg/kg twice daily, n=7) (L-NCT), high-dose NCT (2 mg/kg twice daily, n=7) (H-NCT),

114 T plus enalapril (10 mg twice daily, n=8) (L-NCT+ENA), or placebo (PL, n=8).

115 L-NCT and L-NCT+ENA prevented progressive LV remodeling, as evidence

116 L-NCT alone and L-NCT+ENA reduced tNEPI toward normal (28+/-4 and 39+/-17

117 se NCT (2 mg/kg twice daily, n=7) (H-NCT), L-NCT plus enalapril (10 mg twice daily, n=8) (L-NCT+ENA),

118 The addition of ENA to L-NCT afforded a greater increase in LV systolic function.

119 ogs, LVEF decreased but was unchanged with L-NCT and increased with L-NCT+ENA.

120 In dogs with HF, therapy with L-NCT prevented progressive LV dysfunction and remodeling.

121 as unchanged with L-NCT and increased with L-NCT+ENA.

122 a-dependent nuclear import of 53BP1, a large NCT cargo.

123 e "open" and "closed" states of the lid-like NCT with respect to a hydrophilic loop 1 (HL1) on PS1, t

124 Collectively, our data link NCT defects to ALS-associated cellular pathology and pro

125 ntibody recognized fully glycosylated mature NCT in the active gamma-secretase complex on the cell su

126 omplete picture of potential polyPR-mediated NCT defects.

127 In addition, trauma-mediated NCT defects and lethality are rescued by nuclear export

128 d quantified microbiota-derived metabolites (NCT #04552834).

129 a trans-Golgi network (TGN) targeting motif (NCT-TGN) along with PS1, APH-1, and PEN-2 and examined g

130 f therapy with the DBH inhibitor nepicastat (NCT) on the progression of left ventricular (LV) dysfunc

131 Nicastrin (NCT) is a crucial component of the gamma-secretase (GS)

132 Nicastrin (NCT) is a type I integral membrane protein that is one o

133 nterior pharynx defect-1 (APH-1), nicastrin (NCT) and PEN-2 and early-onset; autosomal dominant forms

134 rior pharynx-defective 1 (APH-1), nicastrin (NCT), and presenilin enhancer 2 (PEN-2) is of significan

135 f the components of this complex, nicastrin (NCT), functions as a receptor for gamma-secretase substr

136 Here, we show that only a form of nicastrin (NCT) containing N-linked complex oligosaccharides is pre

137 ghly glycosylated, mature form of nicastrin (NCT), Aph-1, and Pen-2.

138 F), a mature glycosylated form of nicastrin (NCT), Aph-1, and Pen-2.

139 protease comprised of presenilin, nicastrin (NCT), anterior pharynx defective 1 and PEN-2.

140 complex, composed of presenilin, nicastrin (NCT), anterior pharynx-defective 1 (APH-1), and presenil

141 exes containing presenilins (PS), nicastrin (NCT), APH-1, and PEN-2 mediate the gamma-secretase cleav

142 , consisting of presenilins (PS), nicastrin (NCT), APH-1, and PEN-2, catalyzes the intramembranous pr

143 cretase complex--presenilin (PS), nicastrin (NCT), Pen2, and Aph1--are all thought to be essential fo

144 consisting of presenilins (PSs), nicastrin (NCT), APH-1, and PEN-2.

145 enilin (PSEN, catalytic subunit), Nicastrin (NCT), Presenilin Enhancer 2 (PEN-2), and Anterior Pharyn

146 ase is composed of four subunits: nicastrin (NCT) in the extracellular (EC) domain, presenilin-1 (PS1

147 Recent studies indicate that nicastrin (NCT) and presenilins form functional components of a mul

148 rticipants in cancer clinical trials with no NCT identifier on any submitted Medicare claims.

149 The in vitro activity of NCT was evaluated by incubating different Ad serotypes w

150 s key signaling protease: the association of NCT with gamma-secretase is tightly regulated via glycos

151 irst NCT cycle (MR2), and upon completion of NCT (MR3).

152 Ad serotypes with several concentrations of NCT for 1 hour and determining the reduction in Ad titer

153 an increase in ADC after the first cycle of NCT correlates well with pCR after the chemotherapy in o

154 Further development of NCT as a topical antimicrobial is indicated.

155 th the PS holoprotein in complexes devoid of NCT and Aph-1.

156 y A5226A against the extracellular domain of NCT, generated by using a recombinant budded baculovirus

157 of NCT by associating with immature forms of NCT and, consequently, prevents its association with the

158 and TM domains, near the interlobe groove of NCT, emerges as an allo-targeting site that would impact

159 pendence makes direct polyPR interference of NCT a potential mechanistic pathway of C9orf72 toxicity.

160 to be a pivot around which the two lobes of NCT rotate.

161 ar envelope (NE) that drives the majority of NCT.

162 vealed that scFvG9 impairs the maturation of NCT by associating with immature forms of NCT and, conse

163 presenilin severely limits the maturation of NCT, yet combined overexpression of both proteins does n

164 so enable control over the microstructure of NCT lattices by balancing the enthalpic and entropic fac

165 Overexpression of NCT does not generate more of this mature protein, a phe

166 linical trial as measured by the presence of NCT identifiers in Medicare claims.

167 Applying principles of NCT, we computed regional (1) average and (2) modal cont

168 T identifier when present, the proportion of NCT identifiers that corresponded to trials that were al

169 The proportion of NCT-AE was similar with both regimens (3HP-DOT = 6.4% vs

170 red cellular physiology modulate the rate of NCT, as monitored using synthetic and natural cargo, and

171 er GTP availability can regulate the rate of NCT, impacting fundamental cellular processes that exten

172 eus alter GTP availability and thus rates of NCT, regulating RNA export and protein synthesis.

173 arguing instead that the Glu-333 residue of NCT predicted to participate in substrate recognition on

174 The role of NCT has been challenged recently by the observation that

175 vide further evidence supporting the role of NCT in substrate recognition.

176 unction coupling approaches, the strength of NCT lies in its capacity to predict the patterns of exte

177 sotropic network model, reveals two types of NCT motions, bending and twisting, with respect to PS1.

178 that lacks the lid entirely, or a variety of NCT variants that harbor mutations at highly conserved r

179 The sensitivity and versatility of NCT make it a powerful new tool for quantifying mRNA tra

180 One NCT was found to be consistently mutated in a panel of e

181 es from cells expressing NCT-ER, NCT-TGN, or NCT-WT contain identical levels of PS1 derivatives that

182 sing PS1, APH-1, PEN-2, and either NCT-WT or NCT-ER.

183 field corresponding to 32 950 unique patient-NCT identifier pairs.

184 When performing NCT measurements in 1 eye and CLS measurements in the co

185 Pre-NCT T status, race, and ER status were independent predi

186 xtracellular interface between the protease (NCT, PSEN) and the substrate (APP) represents the target

187 catalytic domain resides within PS proteins, NCT has been suggested to be critical for substrate reco

188 mammalian, and yeast cells suggest that PS, NCT, Aph-1, and Pen-2 are necessary and sufficient to re

189 nine hundred twenty-eight patients received NCT; 1,762 patients (91%) had some response, 107 (6%) ha

190 th stage I to III breast cancer who received NCT (anthracycline and/or taxane based).

191 y ill trauma patients cannot be recommended (NCT 01180894).

192 Regional NCT measures can reflect the status of the residual lang

193 ion compared to Italians.Trial registration: NCT, NCT06384326.

194 nges in the activity of the RanGTP-regulated NCT modulate the rate of the cell cycle and the efficien

195 of the protein itself, underlie our reported NCT defects.

196 an impact on the AL rate after EC resection (NCT 01927016).

197 or contain cysteine as the internal residue (NCT/S).

198 A randomised phase 3 trial of rigosertib (NCT 02562443) is underway in specific subgroups of patie

199 , this site is characterized by the sequence NCT, where the cysteine is thought to be involved in an

200 endoplasmic reticulum (ER) retention signal (NCT-ER) or a trans-Golgi network (TGN) targeting motif (

201 gonal supramolecular chemistries in a single NCT system makes it possible to dictate the morphologies

202 patients at risk for progression on standard NCT.

203 g the 2012/2013 season in the United States (NCT: 01427309).

204 gistry is a prospective observational study (NCT: 02,685,631).

205 ynthetic antibodies that specifically target NCT and expressed them in the single-chain variable frag

206 ition of gamma-secretase, and that targeting NCT might be a novel therapeutic strategy against cancer

207 tudies with novel-colonoscopic technologies (NCT) in subjects undergoing screening, diagnostic or sur

208 ofovir was significantly more effective than NCT in several outcome measures in both rabbit studies.

209 assembly, activity, and stability, and that NCT with the mutation of the proposed pivot rescues gamm

210 RNA knockdown experiments demonstrated that NCT-independent gamma-secretase activity requires the pr

211 Our data provide compelling evidence that NCT is a molecular target for the mechanism-based inhibi

212 Here, we report that NCT is dispensable for gamma-secretase activity.

213 The NCT and HAT seem to achieve a measurement closest to the

214 The NCT and saline groups were treated five times daily for

215 The NCT provides a convenient means for computing Dice coeff

216 ometers: 0.2 mmHg (-3.8 to 4.3 mmHg) for the NCT to 2.7 mmHg (-4.1 to 9.6 mmHg) for the Ocuton S.

217 at least 1 claim with a value entered in the NCT identifier field corresponding to 32 950 unique pati

218 Among those in the NCT-AE group, being non-Hispanic and receiving 3HP-DOT,

219 Among those in the NCT-O group, receiving 9H-SAT, missing >/=1 early visit,

220 Here, we investigated the NCT pathway in models of amyotrophic lateral sclerosis-f

221 were used to estimate the missingness of the NCT identifier in claims by calculating the proportion o

222 To estimate the accuracy of the NCT identifier when present, the proportion of NCT ident

223 The presence of the NCT identifiers in claims for Medicare patients particip

224 The adoption of the NCT will make it easier for network neuroscience researc

225 ratified cross-validation was applied on the NCT-CRC-HE-100K dataset.

226 rsome nanocarriers (NLS-NCs) and studied the NCT mechanism underlying their selective nuclear uptake.

227 These findings indicate that the NCT lid is not an essential element necessary for gamma-

228 We also demonstrate that the NCT-E333A mutant is deficient in its binding to substrat

229 ns to illustrate how researchers can use the NCT to report their own findings.

230 Network control theory (NCT) is a simple and powerful tool for studying how netw

231 Network control theory (NCT) provides a unique, quantitative approach to assess

232 ationships that uses network control theory (NCT) to estimate regions' intrinsic neural timescales (I

233 is study, we applied network control theory (NCT) to fully harness the concept of brain networks as d

234 The Noticing, Collecting, Thinking (NCT) model of qualitative data analysis was used to iden

235 Thus, NCT acts to stabilize gamma-secretase but is not require

236 These findings indicate that TBI leads to NCT defects, which potentially mediate the TDP-43 pathol

237 of transport components have been linked to NCT impairments in R-DPR-expressed cells, but the molecu

238 cy was 84% for an early prediction of pCR to NCT.

239 ify patients among exceptional responders to NCT with a low risk for axillary metastases when breast

240 riables are also associated with response to NCT, novel molecular predictors are needed to identify p

241 Neutron computed tomography (NCT) provides an alternative contrast to X-rays, and in

242 mic contour tonometer, noncontact tonometer (NCT), ocular response analyzer, Ocuton S, handheld appla

243 eveloped the Network Correspondence Toolbox (NCT) to permit researchers to examine and report spatial

244 e this, we developed nascent chain tracking (NCT), a technique that uses multi-epitope tags and antib

245 off host cell nucleocytoplasmic trafficking (NCT) by inducing hyperphosphorylation of nuclear pore pr

246 and disrupted nucleocytoplasmic trafficking (NCT) contribute to TDP-43 mislocalization, but how these

247 acromolecular nuclear-cytoplasmic transport (NCT) and ionic transport across the cell membrane during

248 ase-regulated nuclear-cytoplasmic transport (NCT).

249 Nucleocytoplasmic transport (NCT) decline occurs with aging and neurodegeneration.

250 and compromised nucleocytoplasmic transport (NCT) functions.

251 Disrupted nucleocytoplasmic transport (NCT) has been implicated in neurodegenerative disease pa

252 Defective nucleocytoplasmic transport (NCT) has emerged as a contributing factor in the pathoge

253 e disruption of nucleocytoplasmic transport (NCT) is an important mechanism in neurodegenerative dise

254 ough defects in nucleocytoplasmic transport (NCT) is reported ALS and other neurodegenerative disease

255 ough defects in nucleocytoplasmic transport (NCT) may be central to the pathogenesis of ALS and other

256 mplex (NPC) and nucleocytoplasmic transport (NCT) proteins as well as alter nucleoporin stability.

257 is necessitates nucleocytoplasmic transport (NCT) to bypass nuclear pore complexes (NPCs).

258 Nucleocytoplasmic transport (NCT), the facilitated diffusion of cargo molecules betwe

259 Overall rates of noncompletion of treatment (NCT) for latent tuberculosis infection (LTBI) in the PRE

260 er, parallel treatment group clinical trial (NCT 00344643).

261 tions to report the National Clinical Trial (NCT) identifier on claims for items and services related

262 National Clinical Trial (NCT) Identifier: NCT03925883.

263 tive, parallel, randomized controlled trial (NCT 01428050), comparing lactated Ringers (LAR) (15 mL/k

264 In this physiological trial (NCT#03070184), we measured the NP [mid-regional atrial N

265 is a secondary analysis of the SEARCH trial (NCT:01864603), in which 32 communities underwent baselin

266 r neuroprotection in the ELGAN (PENUT Trial, NCT# 01378273).

267 ic covalent bond formation) are used to tune NCT assembly as a function of multiple external stimuli

268 ic study evaluated 62 patients who underwent NCT.

269 m was found in 31 of 36 sessions (86%) using NCT and in all sessions (100%) using CLS.

270 of the fellow eye was measured hourly using NCT.

271 cellular processes that extensively utilize NCT.

272 By elucidating their ability to utilize NCT, these findings demonstrate the efficacy of polymers

273 y of compositionally and structurally varied NCT-based materials is the development of different supr

274 In vitro, NCT demonstrated concentration-dependent direct inactiva

275 The mechanism by which NCT associates with the gamma-secretase complex and regu

276 ective was to assess factors associated with NCT for LTBI among adult participants enrolled at US and

277 Factors associated with NCT, such as missing a clinic visit early during treatme

278 concomitant medication were associated with NCT-AE.

279 ing 9H-SAT, and smoking were associated with NCT-O.

280 hAPH-1 in the absence of PS, consistent with NCT and APH-1 forming a subcomplex prior to association

281 asurements in only 1 eye, and 1 session with NCT measurements in both eyes were performed.

282 Two sessions with NCT measurements in 1 eye and CLS measurements in the fe

283 R2+/TN (T1/T2 and N0/N1) cancer treated with NCT followed by standard breast and nodal surgery from J

284 cells in a manner indistinguishable from WT NCT.